National Hospital Organization Shibukawa Medical Center

Shibukawa-shi, Gunma 377-0280

0 studies enrolling now · 2 studies all time

What they study most

Refractory Multiple Myeloma, Relapsed Multiple Myeloma, Relapsed or Refractory Multiple Myeloma

Studies at this site

• Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma. — Completed
• A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma — Completed